promising egfr inhibitors in development for nsclc
Published 6 years ago • 282 plays • Length 6:03Download video MP4
Download video MP3
Similar videos
-
1:47
egfr inhibitors in development for nsclc
-
6:14
third-generation egfr inhibitors in nsclc
-
4:28
overcoming resistance to egfr inhibitors in nsclc
-
3:28
emerging egfr inhibitors in nsclc
-
3:35
novel egfr inhibitor combinations for nsclc
-
4:48
third-generation egfr inhibitors in nsclc
-
7:31
newer egfr inhibitors in nsclc
-
3:41
egfr inhibitors as adjuvant therapy in nsclc
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
8:30
third-generation egfr inhibitors in nsclc
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
0:43
dr. jackman on overcoming resistance to egfr inhibitors in lung cancer
-
2:27
combining egfr and vegf inhibitors for nsclc
-
2:23
dr. zhu on primary resistance to osimertinib in egfr-mutant nsclc
-
0:59
dr. west on emerging changes in the field of egfr-mutant nsclc
-
18:06
egfr inhibitors in mutation ( ) patients: current therapeutic strategies in the frontline setting
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
9:39
emerging therapies in egfr-positive nsclc